zsan News

Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs this past week than any week in 2014, a year that had over 100 from the sector. With 14 IPOs to date, January 2015 fell...read more

Zosano Pharma, which is developing a transdermal formulation of an approved osteoporosis treatment, raised $50 million on Tuesday by offering 4.5 million shares (upsized from 4.3 million shares) at $11, the midpoint of the range of $10 to $12. The day before, the company had filed to increase the number of shares offered from 3.0 million to 4.3 million, increasing the proposed deal...read more

Zosano Pharma, which is developing a transdermal formulation of an approved osteoporosis treatment, increased the proposed deal size for its upcoming IPO on Monday. The Fremont, CA-based company now plans to raise $47 million by offering 4.3 million shares at a price range of $10 to $12, up from 3.0 million shares at the same range. At the midpoint, Zosano Pharma will raise 43%...read more

Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the twelve deals are health care, as last year's most popular sector continues to outperform. Assuming they all price, there...read more